Jean F. Voltaire

Array ( [id] => 8305901 [patent_doc_number] => 08227434 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-07-24 [patent_title] => 'Materials and methods for treating oncological disorders' [patent_app_type] => utility [patent_app_number] => 10/983009 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 74 [patent_no_of_words] => 13421 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10983009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906212 [patent_doc_number] => 20050101607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/980665 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101607.pdf [firstpage_image] =>[orig_patent_app_number] => 10980665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249979 [patent_doc_number] => 20050142104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders' [patent_app_type] => utility [patent_app_number] => 10/981190 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25910 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142104.pdf [firstpage_image] =>[orig_patent_app_number] => 10981190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939840 [patent_doc_number] => 20050113403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Method of treating mantle cell lymphoma' [patent_app_type] => utility [patent_app_number] => 10/979284 [patent_app_country] => US [patent_app_date] => 2004-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6043 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113403.pdf [firstpage_image] =>[orig_patent_app_number] => 10979284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808337 [patent_doc_number] => 20060094692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Pharmaceutical formulations of camptothecins and process for making same' [patent_app_type] => utility [patent_app_number] => 10/976203 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5067 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094692.pdf [firstpage_image] =>[orig_patent_app_number] => 10976203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939743 [patent_doc_number] => 20050113306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods of treating cancer and the pain associated therewith using endothelin antagonists' [patent_app_type] => utility [patent_app_number] => 10/974170 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9358 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113306.pdf [firstpage_image] =>[orig_patent_app_number] => 10974170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939757 [patent_doc_number] => 20050113320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Use of calphostin C to treat drug-resistant tumor cells' [patent_app_type] => utility [patent_app_number] => 10/974310 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10232 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113320.pdf [firstpage_image] =>[orig_patent_app_number] => 10974310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939744 [patent_doc_number] => 20050113307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods of treating cancer and the pain associated therewith using endothelin antagonists' [patent_app_type] => utility [patent_app_number] => 10/974171 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9340 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113307.pdf [firstpage_image] =>[orig_patent_app_number] => 10974171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983977 [patent_doc_number] => 20050154047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Melatonin analogue prodrugs' [patent_app_type] => utility [patent_app_number] => 10/973692 [patent_app_country] => US [patent_app_date] => 2004-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2048 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20050154047.pdf [firstpage_image] =>[orig_patent_app_number] => 10973692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906269 [patent_doc_number] => 20050101664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Prodrugs of carbamate inhibitors of IMPDH' [patent_app_type] => utility [patent_app_number] => 10/963955 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12896 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101664.pdf [firstpage_image] =>[orig_patent_app_number] => 10963955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7084051 [patent_doc_number] => 20050049431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases' [patent_app_type] => utility [patent_app_number] => 10/962250 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12925 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049431.pdf [firstpage_image] =>[orig_patent_app_number] => 10962250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255502 [patent_doc_number] => 20050075358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Methods for treating IGF1R-inhibitor induced hyperglycemia' [patent_app_type] => utility [patent_app_number] => 10/958869 [patent_app_country] => US [patent_app_date] => 2004-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9654 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075358.pdf [firstpage_image] =>[orig_patent_app_number] => 10958869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7223666 [patent_doc_number] => 20050261171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Combination cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/957951 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10016 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261171.pdf [firstpage_image] =>[orig_patent_app_number] => 10957951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256077 [patent_doc_number] => 20050143315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy' [patent_app_type] => utility [patent_app_number] => 10/957507 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2215 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143315.pdf [firstpage_image] =>[orig_patent_app_number] => 10957507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256077 [patent_doc_number] => 20050143315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy' [patent_app_type] => utility [patent_app_number] => 10/957507 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2215 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143315.pdf [firstpage_image] =>[orig_patent_app_number] => 10957507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712305 [patent_doc_number] => 08093230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Supersaturated aqueous ifosfamide compositions' [patent_app_type] => utility [patent_app_number] => 10/952027 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1697 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093230.pdf [firstpage_image] =>[orig_patent_app_number] => 10952027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020035 [patent_doc_number] => 20050222054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Combination comprising a CDK inhibitor and doxorubicin' [patent_app_type] => utility [patent_app_number] => 10/952575 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6743 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222054.pdf [firstpage_image] =>[orig_patent_app_number] => 10952575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127950 [patent_doc_number] => 20050059694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'New use of 11.28-dioxa-4-azatricyclo [22.3.1.04,9] octacos-18-ene derivatives and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/948188 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3087 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059694.pdf [firstpage_image] =>[orig_patent_app_number] => 10948188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829254 [patent_doc_number] => 20060063833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Ready-to-use oxaliplatin solutions' [patent_app_type] => utility [patent_app_number] => 10/947604 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7678 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063833.pdf [firstpage_image] =>[orig_patent_app_number] => 10947604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570116 [patent_doc_number] => 07462642 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Anti-cancer combinations' [patent_app_type] => utility [patent_app_number] => 10/946833 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6809 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462642.pdf [firstpage_image] =>[orig_patent_app_number] => 10946833 [rel_patent_id] =>[rel_patent_doc_number] =>)